Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06555601
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-25
Brief Title:
A First-in-human Study to Evaluate the Safety Tolerability and Pharmacokinetics of UCB3101 in Healthy Participants
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A First-in-Human Randomized Investigator-Blind Participant-Blind Placebo-Controlled Study to Evaluate the Safety Tolerability and Pharmacokinetics of Single Ascending Doses of UCB3101 in Healthy Participants
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the study is to evaluate the safety and tolerability of a single ascending dose of UCB3101 in cohorts of healthy male and female study participants
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None